Pet Cancer Therapeutics Market Report 2021
Report Code: KNJ848962 No. of Pages: 122 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Extract: Based on this comprehensive report published by Gravitas Market Insights, the Pet Cancer Therapeutics market is said to witness a significant growth during the forecast years between 2021 and 2028. Cancer in pets can take many forms, including soft tissue sarcomas and mast cell tumours, which can be cured or prevented from spreading with long-term treatment. Pet cancer therapeutics are novel anti-cancer drugs that are used to treat cancer and are capable of suppressing the effect of cancerous cells and limiting their growth. When incurable forms of cancer emerge, veterinary professionals' goal is to prolong survival while maintaining or improving the pet's quality of life and reducing pain. Report Scope in detail: This latest report edition of Pet Cancer Therapeutics market has been added to our huge database of detailed reports and this envisions to shape the future of all the related businesses. Our team of learned research analysts have studied in-depth and curated the report based on several aspects which include the overview of the market, driving forces, growth rate, market trends, market size, opportunities and challenges of the market; along with detailed competitive analysis on the regional as well as global level. The Pet Cancer Therapeutics market research report renders a thorough analysis of the market on a global aspect and aims on several market segmentation. This report also provides deeper perception into the latest trends of the market and pinpoints crucial product developments of the industry. Furthermore, the report collects numerous factors that have accredited to the growth of the market in the recent years. Market Dynamics: • The increasing prevalence of cancers in cats and dogs, as well as heavy investments in research and development activities related to oncology treatment and management in pets, are major factors driving the growth of the pet cancer therapeutics market. • Growing awareness of pet healthcare and treatments available in the market, as well as the presence of a large number of marketed drugs and vaccines for cancer treatment, are expected to further propel the market. • The adverse effects of cancer therapeutics for the treatment of oncology conditions in pets, as well as pet owners' ignorance about putting their pets on medications, are stifling growth. Pet Cancer Therapeutics Market Segmentation: By Therapy • Immunotherapy • Chemotherapy • Radiation therapy • Other Therapies By Animals • Dog • Cat • Other Animals By Application • Melanoma • Lymphoma • Mast Cell Cancer • Mammary and Squamous Cell Cancer • Other Application Regional Coverage • North America o United States o Canada o Mexico • Europe o UK o Germany o France o Italy o Spain o Russia o Rest of Europe • Asia Pacific o China o India o Japan o Korea o Australia o Southeast Asia o Rest of Asia-Pacific • South America o Brazil o Argentina o Colombia o Rest of South America • Middle East & Africa o GCC o South Africa o Rest of Middle East & Africa Competitive Analysis: Eminent market players have been outlined in order to extract improved insights into the worldwide businesses. Our research reports offer all-inclusive information on various top most manufacturers that are operational across global regions. We provide company profiles which include detailed overview of the company, business information, business performance, crucial strategies implemented through the years. Few of the Key Players Covered in Our Report: • Boehringer Ingelheim GmbH (Merial) • AB Science • Karyopharm Therapeutics, Inc. • Elanco • VetDC Inc. • AdvaVet Inc. • ELIAS Animal Health • Rhizen Pharmaceuticals SA • Virbac • Zoetis Impact of COVID19: The COVID19 pandemic crippled the global economy, it resulted in a worldwide lockdown and this has majorly impacted numerous industries. Our industry experts are working round-the-clock to identify, accumulate and in-time deliver market analysis due to the effect of unprecedented decisions in COVID-19 repercussions on many businesses. The full version of this report will comprise the overall impact of the pandemic, and predicted alteration on the future outlook of the industry, by taking into the account the economic, political, technological and social parameters.
Section 1: Executive Summary 1.1. Pet Cancer Therapeutics Market Industry 360° outline, Year 2016 – 2028 1.2. Business Model Trends 1.3. Growth Trends 1.4. End-User/Animals Trends 1.5. Regional Trends Section 2: Market Dynamics - Pet Cancer Therapeutics Market Industry Insights 2.1. Growth Drivers 2.2. Opportunities 2.3. Industry challenges 2.4. SWOT Analysis 2.5. Porter’s Analysis 2.6. Worldwide Industry Landscape, Year 2016 – 2028 2.7. Industry Segmentation 2.8. Technology & Invention landscape 2.9. Regional Landscape 2.9.1. North America 2.9.2. Europe 2.9.3. Asia-Pacific 2.9.4. South America 2.9.5. Middle East & Africa 2.10. Competitive Environment Section 3: Global Pet Cancer Therapeutics Market, By Therapy 3.1. Segmentation Analysis, By Therapy, 2016-2028 3.2. Market Share Segmentation Analysis, By Therapy, 2016-2028 3.3. Immunotherapy 3.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 3.4. Chemotherapy 3.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 3.5. Radiation therapy 3.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 3.6. Other Therapies 3.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 Section 4: Global Pet Cancer Therapeutics Market, By Animals 4.1. Segmentation Analysis, By Animals, 2016-2028 4.2. Market Share Segmentation Analysis, By Animals, 2016-2028 4.3. Dog 4.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 4.4. Cat 4.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 4.5. Other Animals 4.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 Section 5: Global Pet Cancer Therapeutics Market, By Application 5.1. Segmentation Analysis, By Application, 2016-2028 5.2. Market Share Segmentation Analysis, By Application, 2016-2028 5.3. Melanoma 5.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.4. Lymphoma 5.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.5. Mast Cell Cancer 5.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.6. Mammary and Squamous Cell Cancer 5.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.7. Other Application 5.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 Section 6: Global Pet Cancer Therapeutics Market, Regional Analysis 6.1. Global Pet Cancer Therapeutics Market, Regional Analysis 6.2. North America, Country level Analysis 6.2.1. North America Pet Cancer Therapeutics Market estimates and forecast with Growth rate analysis, By Therapy, 2016 – 2028 6.2.2. North America Pet Cancer Therapeutics Market estimates and forecast with Growth rate analysis, By Animals, 2016 – 2028 6.2.3. North America Pet Cancer Therapeutics Market estimates and forecast with Growth rate analysis, By Application, 2016 – 2028 6.2.4. United States 6.2.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 6.2.5. Canada 6.2.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 6.2.6. Mexico 6.2.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 6.3. Europe Country level Analysis 6.3.1. Europe Pet Cancer Therapeutics Market estimates and forecast with Growth rate analysis, By Therapy, 2016 – 2028 6.3.2. Europe Pet Cancer Therapeutics Market estimates and forecast with Growth rate analysis, By Animals, 2016 – 2028 6.3.3. Europe Pet Cancer Therapeutics Market estimates and forecast with Growth rate analysis, By Application, 2016 – 2028 6.3.4. UK 6.3.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 6.3.5. Germany 6.3.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 6.3.6. France 6.3.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 6.3.7. Italy 6.3.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 6.3.8. Spain 6.3.8.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 6.3.9. Russia 6.3.9.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 6.3.10. Rest of Europe 6.3.10.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 6.4. Asia-Pacific Country level Analysis 6.4.1. Asia-Pacific Pet Cancer Therapeutics Market estimates and forecast with Growth rate analysis, By Therapy, 2016 – 2028 6.4.2. Asia-Pacific Pet Cancer Therapeutics Market estimates and forecast with Growth rate analysis, By Animals, 2016 – 2028 6.4.3. Asia-Pacific Pet Cancer Therapeutics Market estimates and forecast with Growth rate analysis, By Application, 2016 – 2028 6.4.4. China 6.4.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 6.4.5. India 6.4.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 6.4.6. Japan 6.4.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 6.4.7. Korea 6.4.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 6.4.8. Australia 6.4.8.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 6.4.9. Southeast Asia 6.4.9.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 6.4.10. Rest of Asia-Pacific 6.4.10.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 6.5. South America Country level Analysis 6.5.1. South America Pet Cancer Therapeutics Market estimates and forecast with Growth rate analysis, By Therapy, 2016 – 2028 6.5.2. South America Pet Cancer Therapeutics Market estimates and forecast with Growth rate analysis, By Animals, 2016 – 2028 6.5.3. South America Pet Cancer Therapeutics Market estimates and forecast with Growth rate analysis, By Application, 2016 – 2028 6.5.4. Brazil 6.5.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 6.5.5. Argentina 6.5.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 6.5.6. Colombia 6.5.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 6.5.7. Rest of South America 6.5.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 6.6. Middle East & Africa Country level Analysis 6.6.1. MEA Pet Cancer Therapeutics Market estimates and forecast with Growth rate analysis, By Therapy, 2016 – 2028 6.6.2. MEA Pet Cancer Therapeutics Market estimates and forecast with Growth rate analysis, By Animals, 2016 – 2028 6.6.3. MEA Pet Cancer Therapeutics Market estimates and forecast with Growth rate analysis, By Application, 2016 – 2028 6.6.4. GCC 6.6.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 6.6.5. South Africa 6.6.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 6.6.6. Rest of Middle East & Africa 6.6.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 Section 7: Company Profile - Pet Cancer Therapeutics Market 7.1. Boehringer Ingelheim GmbH (Merial) 7.1.1. Business Overview 7.1.2. Product & Service Offering 7.1.3. Overall Revenue 7.1.4. Strategic Outlook 7.2. AB Science 7.2.1. Business Overview 7.2.2. Product & Service Offering 7.2.3. Overall Revenue 7.2.4. Strategic Outlook 7.3. Karyopharm Therapeutics, Inc. 7.3.1. Business Overview 7.3.2. Product & Service Offering 7.3.3. Overall Revenue 7.3.4. Strategic Outlook 7.4. Elanco 7.4.1. Business Overview 7.4.2. Product & Service Offering 7.4.3. Overall Revenue 7.4.4. Strategic Outlook 7.5. VetDC Inc. 7.5.1. Business Overview 7.5.2. Product & Service Offering 7.5.3. Overall Revenue 7.5.4. Strategic Outlook 7.6. AdvaVet Inc. 7.6.1. Business Overview 7.6.2. Product & Service Offering 7.6.3. Overall Revenue 7.6.4. Strategic Outlook 7.7. ELIAS Animal Health 7.7.1. Business Overview 7.7.2. Product & Service Offering 7.7.3. Overall Revenue 7.7.4. Strategic Outlook 7.8. Rhizen Pharmaceuticals SA 7.8.1. Business Overview 7.8.2. Product & Service Offering 7.8.3. Overall Revenue 7.8.4. Strategic Outlook 7.9. Virbac 7.9.1. Business Overview 7.9.2. Product & Service Offering 7.9.3. Overall Revenue 7.9.4. Strategic Outlook 7.10. Zoetis 7.10.1. Business Overview 7.10.2. Product & Service Offering 7.10.3. Overall Revenue 7.10.4. Strategic Outlook *Market size and forecast will be provided from 2016-2028, and forecast period would be 2021-2028 *Details on financial performance and strategic moves and developments may not be captured for unlisted companies *List of companies profiled in this TOC is tentative and may change after detailed analysis
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com